Beyond the well-known oncogenic driver MYCN that is amplified in almost 20% of high-risk NB, elevated MYC expression is an independent marker and defines a distinct high-risk subset in approximately 10% of cases 3, while its roles and protein partners in NB progression require systematic interrogation. The gene discussed is MYCN; the disease is neuroblastoma.